Veröffentlichungsdatum: 18 Januar 2019
Projektträger – zwischengeschaltetes Finanzinstitut
The project consists of the financing of Novozymes' research, development and innovation (RDI) activities for the development of biological solutions, industrial enzymes and microorganisms.
The RDI activities will focus on the development of products and solutions that enhance product quality and process/energy efficiency in industries such as detergents, food and beverages, bioenergy, agriculture and feed and technical industries.
- Industrie - Verarbeitendes Gewerbe/Herstellung von Waren
Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)
EUR 100 million
Gesamtkosten (voraussichtlicher Betrag)
EUR 272 million
The project concerns investments in research and development that are expected to be carried out in existing facilities, already authorised, and which would therefore not require an environmental impact assessment (EIA) 2014/52/EU amending the EIA Directive 2011/92/EC. Full environmental details will be verified during the appraisal.
The promoter is a private company not operating in the utilities sector, and is thus not covered by EU directives on procurement.
Unterzeichnet - 7/01/2019
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).